☰

Paul Cheng, Ph.D. - Publications

Affiliations: 
2012 Bioengineering University of California, San Francisco, San Francisco, CA 
Area:
Biomedical Engineering, Human Development
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nagao M, Lyu Q, Zhao Q, Wirka RC, Bagga J, Nguyen T, Cheng P, Kim JB, Pjanic M, Miano JM, Quertermous T. Coronary Disease Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway. Circulation Research. PMID 31815603 DOI: 10.1161/Circresaha.119.315968  0.335
2018 Iyer D, Zhao Q, Wirka R, Naravane A, Nguyen T, Liu B, Nagao M, Cheng P, Miller CL, Kim JB, Pjanic M, Quertermous T. Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk. Plos Genetics. 14: e1007681. PMID 30307970 DOI: 10.1371/Journal.Pgen.1007681  0.324
2017 De Santo C, Booth S, Vardon A, Cousins A, Tubb V, Perry T, Noyvert B, Beggs A, Ng M, Halsey C, Kearns P, Cheng P, Mussai F. The arginine metabolome in Acute Lymphoblastic Leukemia can be targeted by the PEG-recombinant Arginase I BCT-100. International Journal of Cancer. PMID 29168171 DOI: 10.1002/Ijc.31170  0.336
2015 Mussai FJ, Booth S, Vardon A, Ng M, Cheng P, De Santo C. Cytotoxicity of the Recombinant Human Arginase (BCT-100) Against Acute Lymphoblastic Leukaemia (ALL) Blood. 126: 4916-4916. DOI: 10.1182/Blood.V126.23.4916.4916  0.32
2014 Mussai FJ, Egan S, Higginbotham-Jones J, Lo A, Ng M, Perry TA, Loke J, Beggs AD, Pratt G, Kearns PR, Cheng P, DeSanto C. Cytotoxicity of the Recombinant Human Arginase (BCT-100) Against Acute Myeloid Leukaemia (AML) Blood. 124: 2317-2317. DOI: 10.1182/Blood.V124.21.2317.2317  0.32
2013 Limphong P, Zhang H, Christians E, Liu Q, Riedel M, Ivey K, Cheng P, Mitzelfelt K, Taylor G, Winge D, Srivastava D, Benjamin I. Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells. Stem Cells Translational Medicine. 2: 161-6. PMID 23430692 DOI: 10.5966/Sctm.2012-0073  0.304
2010 van Laake LW, Qian L, Cheng P, Huang Y, Hsiao EC, Conklin BR, Srivastava D. Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance. Circulation Research. 107: 340-7. PMID 20558827 DOI: 10.1161/Circresaha.109.215434  0.313
2009 Kwon C, Qian L, Cheng P, Nigam V, Arnold J, Srivastava D. A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nature Cell Biology. 11: 951-7. PMID 19620969 DOI: 10.1038/Ncb1906  0.325
Show low-probability matches.